• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证德克萨斯肝癌风险指数预测模型在亚洲人群中对肝癌的预测价值。

Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Soonchunhyang University School of Medicine, Bucheon, Korea.

Department of Statistics, Soonchunhyang University School of Medicine, Bucheon, Korea.

出版信息

Clin Gastroenterol Hepatol. 2024 Sep;22(9):1953-1955.e1. doi: 10.1016/j.cgh.2024.02.028. Epub 2024 Mar 13.

DOI:10.1016/j.cgh.2024.02.028
PMID:38484945
Abstract

Hepatocellular carcinoma (HCC) represents a significant global health burden, with its incidence and mortality rates varying significantly across different geographic regions. This variance is largely attributed to differences in the prevalence of risk factors such as hepatitis B and C infections, and alcohol consumption, as well as genetic predispositions that are distinct between Eastern and Western populations. Moreover, the impact of racial and ethnic diversity on the disease's epidemiology further complicates the global understanding and prediction of HCC. Such disparities highlight the critical need to evaluate the applicability of predictive models across diverse populations, acknowledging that a model developed in one region may not necessarily translate with the same accuracy or effectiveness when applied to another, because of these underlying epidemiologic and genetic differences. In this study, we aimed to assess the cross-regional applicability and accuracy of an HCC prediction model (Texas hepatocellular carcinoma risk index [THCC-RI] predictive model) originally developed in Western populations, within an Eastern context..

摘要

肝细胞癌(HCC)是一个全球性的健康负担,其发病率和死亡率在不同地理区域有很大差异。这种差异主要归因于乙型和丙型肝炎感染、饮酒等危险因素的流行率以及东西方人群之间明显的遗传易感性的差异。此外,种族和民族多样性对疾病的流行病学的影响进一步使全球对 HCC 的理解和预测变得复杂。这些差异突出表明,需要评估预测模型在不同人群中的适用性,认识到在一个地区开发的模型在应用于另一个地区时,由于存在这些潜在的流行病学和遗传差异,其准确性或有效性可能不一定相同。在本研究中,我们旨在评估一个 HCC 预测模型(德克萨斯肝细胞癌风险指数[THCC-RI]预测模型)在东方背景下的跨区域适用性和准确性,该模型最初是在西方人群中开发的。

相似文献

1
Validation of the Texas Hepatocellular Carcinoma Risk Index Predictive Model for Hepatocellular Carcinoma in Asian Cohort.验证德克萨斯肝癌风险指数预测模型在亚洲人群中对肝癌的预测价值。
Clin Gastroenterol Hepatol. 2024 Sep;22(9):1953-1955.e1. doi: 10.1016/j.cgh.2024.02.028. Epub 2024 Mar 13.
2
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.aMAP 风险评分可预测慢性肝炎患者发生肝细胞癌的风险。
J Hepatol. 2020 Dec;73(6):1368-1378. doi: 10.1016/j.jhep.2020.07.025. Epub 2020 Jul 21.
3
Evaluation of ethnic influence in the application of a hepatocellular carcinoma predictive model for chronic hepatitis C.评估种族因素对慢性丙型肝炎肝癌预测模型应用的影响。
J Med Virol. 2021 Nov;93(11):6257-6266. doi: 10.1002/jmv.27168. Epub 2021 Jul 12.
4
The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.肝细胞癌风险预测评分在北美的慢性乙型肝炎感染患者人群中的适用性。
Gut. 2016 Aug;65(8):1347-58. doi: 10.1136/gutjnl-2014-309099. Epub 2015 Apr 30.
5
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.一种用于预测韩国和高加索慢性乙型肝炎患者肝细胞癌风险的人工智能模型。
J Hepatol. 2022 Feb;76(2):311-318. doi: 10.1016/j.jhep.2021.09.025. Epub 2021 Oct 2.
6
What can we learn from hepatitis B virus clinical cohorts?从乙型肝炎病毒临床队列中我们可以学到什么?
Liver Int. 2015 Jan;35 Suppl 1:91-9. doi: 10.1111/liv.12716.
7
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.一大群慢性乙型肝炎白种患者接受口服治疗5年后的肝细胞癌预测
J Hepatol. 2020 Jun;72(6):1088-1096. doi: 10.1016/j.jhep.2020.01.007. Epub 2020 Jan 22.
8
Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.慢性乙型肝炎患者长期肝硬化和肝细胞癌风险的预测模型:整合宿主和病毒特征的风险评分。
Hepatology. 2013 Aug;58(2):546-54. doi: 10.1002/hep.26385.
9
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B.开发一种评分系统,以预测亚洲慢性乙型肝炎抗病毒治疗患者的肝细胞癌。
J Hepatol. 2018 Aug;69(2):278-285. doi: 10.1016/j.jhep.2018.02.032. Epub 2018 Mar 16.
10
Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.利用FIB-4肝纤维化指数预测中度至重度饮酒者未来肝细胞癌的发病率
Cancer. 2015 Nov 1;121(21):3818-25. doi: 10.1002/cncr.29577. Epub 2015 Jul 15.

引用本文的文献

1
Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical application.非酒精性脂肪性肝炎相关肝病(MASLD)遗传学的最新进展:对疾病机制的见解及临床应用的新前沿
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000618. eCollection 2025 Jan 1.
2
Integrating PNPLA3 into clinical risk prediction.将PNPLA3纳入临床风险预测。
Liver Int. 2025 Mar;45(3):e16103. doi: 10.1111/liv.16103. Epub 2024 Sep 16.